Objectives: The aim of the study was the biochemical characterization of a new variant of the metallob-lactamase, IMP-22. Moreover, the genetic environment of the bla IMP-22 gene was investigated in Pseudomonas fluorescens and Pseudomonas aeruginosa collected from urban wastewater and a teaching hospital in L'Aquila, Italy.
Introduction
Carbapenem compounds are highly potent broad-spectrum antimicrobial agents largely used in the clinical therapy of severe and difficult to treat infections. In particular, they play an important role in the treatment of infections caused by Pseudomonas aeruginosa. 1 The production of carbapenemases (serine-and metallo-b-lactamases) is the most common mechanism of resistance in clinical isolates to this class of antibiotics. 2 -4 Metalloenzymes fall into Ambler class B and are distinguished by having one to two zinc ions for their enzymatic activity. Metallo-b-lactamase-mediated resistance in Gram-negative bacteria is emerging worldwide and is mostly due to the mobilization of IMP-and VIM-type metallo-b-lactamases. 2 -4 To date, several variants of IMP-type metallo-b-lactamases have been discovered (K. Bush and G. Jacoby; http://www.lahey.org/Studies) and have been well characterized. 5 -7 bla MBL genes appear very threatening because of their ability to spread rapidly among bacteria of clinical interest.
Most of the transferable metallo-b-lactamases are commonly encoded by genes carried by type 1 and 3 integrons. 3 Thus, integrons are considered as potentially mobile DNA elements with a site-specific recombination site (attI) able to capture genes. Most of the integrons studied, belonging to class 1, have been identified both in Gram-negative clinical isolates, where they contribute significantly to the prevalence and dissemination of antibiotic resistance gene cassettes, 9 and also in environmental strains. 10 -12 Many metallo-b-lactamase genes are present in environmental strains, as reported in several studies. 13 -17 Antibiotic-resistant strains reach the environment through the manure and liquid manure from animals and through human excretion; resistant bacteria may be released directly into wastewater systems from hospitalized and non-hospitalized patients. 18 Since most genetic determinants mediating antibiotic resistance, such as b-lactamase genes, are associated with mobile DNA and are transferred horizontally, these genes may be spread beyond the habitat of the original hosts, across taxonomic barriers. The risk is that typical resistance genes from nosocomial strains could be transferred to environmental bacteria, spreading into several compartments.
Two non-related carbapenem-resistant Pseudomonas fluorescens collected from wastewater specimens were found to harbour a class 1 integron carrying a new IMP variant, IMP-22, which was characterized from a biochemical standpoint. The structures of the integrons were compared with that identified in a carbapenem-resistant P. aeruginosa isolated from a hospitalized patient in a teaching hospital in L'Aquila, Italy.
Materials and methods

Antimicrobial agents
Antibiotics and other reagents were from Sigma Chemical Co. (St Louis, MO, USA) unless otherwise specified. Imipenem was from Merck Research Laboratories (Rahway, NJ, USA), meropenem from Astra-Zeneca Pharmaceuticals (Macclesfield, Cheshire, UK), ceftazidime and clavulanic acid from Glaxo-Wellcome (Verona, Italy), aztreonam and cefepime from Bristol -Myers Squibb Co. (Wallingford, CT, USA), and nitrocefin from Unipath (Milan, Italy).
Strains, plasmids and gene transfer experiments
Two strains of P. fluorescens (AQ/05 and AQ/06) were isolated from water samples collected upstream of the pilot plant of the L'Aquila city urban sewage plant (in the centre of Italy) in 2005 and 2006, respectively. The samples were processed on the same day as follows: 100 mL volumes of several dilutions (10 21 , 10
22
and 10
23
) of the samples in sterile saline solution were plated on Nutrient Agar or MacConkey plates supplemented with ceftazidime (4 mg/L) and imipenem/cilastatin (4 mg/L) in order to select for potential b-lactamase producers. Plates were incubated at 378C for 16 h. Individual resistant colonies were isolated and used for identification of microorganisms.
One strain of P. aeruginosa AQ/07 was isolated in 2007 from a decubitus ulcer of an elderly woman patient hospitalized in the L'Aquila teaching hospital.
The API 20 NE (bioMérieux, Marcy l'É toile, France) identification system was used to identify Gram-negative bacteria. Escherichia coli DH5a (Gibco Life Technologies, Gaithersburg, MD, USA), E. coli BL21(DE3), E. coli BL21(DE3)pLys and E. coli BL21(DE3)Rosetta (Novagen, Inc., Madison, WI, USA) were used as hosts in the transformation experiments performed, as reported by Sambrook et al. Conjugation experiments were carried out in Mueller -Hinton broth (Difco Laboratories, Detroit, MI, USA) using rifampicinresistant P. aeruginosa PAO1 mutant as recipient. Hybridization experiments on plasmid and chromosomal DNA were performed by a Southern blot assay. 19 
Random amplification of polymorphic DNA (RAPD) analysis
Genomic relatedness between two P. fluorescens AQ/05 and AQ/06 strains was investigated by RAPD profiling. RAPD was carried out using primers reported previously. 20 Under these experimental conditions, reproducible profiles were obtained in replicate experiments.
PCR amplification and DNA sequencing
Chromosomal and plasmid DNA were extracted from the strains according to the standard procedure. 19 In order to amplify the metallo-b-lactamase gene, a PCR experiment was performed on chromosomal DNA using primers designed on conserved regions of bla IMP -type genes (Table 1) . Genomic DNA was also screened for the presence of integrons using the primers designed for the 5 0 and 3 0 conserved segments (CSs) of class 1 integrons (Table 1) . IntI1, IntI2, IntI3, qacED1 and sul1 genes were also detected using primer sets designed for this study, as shown in Table 1 . The DNA fragments obtained by PCR were sequenced on both strands according to the dideoxy-chain termination by using an ABI-PRISM 310 (Applied Biosystems, Monza, Italy) automatic sequencer. Sequence analysis was performed on three independent amplification products.
Cloning of the bla IMP-22 gene
The entire bla IMP-22 gene was amplified using two pairs of primers with specific restriction sites (Table 1) at the 5 0 OH of each primer, for cloning into different vector systems: pBC-SK and pET-26b(þ). The PCR products obtained were purified by standard procedures, digested with KpnI/BamHI and NdeI/BamHI endonucleases and ligated into pBC-SK and pET-26b(þ) vectors, respectively. The sequence of the insertion was verified by nucleotide sequencing. The recombinant plasmids pBC-SK/bla IMP-22 and pET-26/bla IMP-22 were inserted by transformation protocol into E. coli DH5a. In order to improve the expression of metallo-b-lactamase, the recombinant plasmid pET-26/bla IMP-22 was inserted into E. coli BL21(DE3), E. coli BL21(DE3)pLys and E. coli BL21(DE3)Rosetta.
Susceptibility testing
MICs were determined by the conventional macrodilution broth procedure, according to the CLSI performance standards. 21 Tazobactam was used at a fixed concentration of 4 mg/L. The combination amoxicillin/clavulanic acid was used at a ratio of 2:1. Results were recorded after incubation for 18 h at 378C.
Expression and purification of IMP-22 metallo-b-lactamase
In order to evaluate the best expression of IMP-22 enzyme, E. coli BL21(DE3)Rosetta harbouring pET-26/bla IMP-22 was grown in different culture media (TB, TSB, LB and M9 minimum medium) and at two different temperatures (37 and 288C) with and without inducers [0.4 mM isopropyl-b-D-thiogalactopyranoside (IPTG)]. The crude extract was obtained as described previously. 22 The clarified sample was loaded onto a Sepharose Q FF column equilibrated with 10 mM HEPES ( pH 7.5) containing 50 mM ZnCl 2 (HB) buffer. The metallo-b-lactamase was eluted with a linear gradient of NaCl (from 0 to 0.5 M) in the same buffer. The active fractions were collected, loaded onto a Superdex 75 gel column at the rate of 1 mL/min and concentrated in an Amicon concentrator system with YM10 membranes (cut-off 10 000 Da). The fractions containing metallob-lactamase activity were pooled, dialysed against HB buffer and loaded onto a Superose 12 column equilibrated with the same buffer. The fractions containing b-lactamase activity were pooled and stored at 2408C.
b-Lactamase assays b-Lactamase activity was assayed spectrophotometrically on crude extract by monitoring imipenem hydrolysis (l¼ 300 nm; De 300 M ¼29000 M 21 cm 21 ) at 258C in HB buffer. The initial substrate concentration was 150 mM. Inhibition of enzymatic activity by EDTA was assayed by measuring the residual carbapenemase activity after incubation of the crude extract for 20 min at 258C in the presence of 10 mM EDTA. A control without EDTA was always carried out in parallel.
Biochemical characterization of IMP-22
SDS-PAGE was performed according to the Laemmli procedure. 23 Protein concentration was determined by the method of Bradford. 24 The isoelectric point ( pI) value was determined by isoelectric focusing analysis in 5% polyacrylamide gels containing ampholytes ( pH range, 3.5-9.5). The focused b-lactamase was detected by the zymogram technique using 250 mM nitrocefin diluted in HB buffer.
The N-terminal sequence was determined with the help of a gasphase sequencer (Procise TM 492, Applied Biosystems, Foster City, CA, USA).
Determination of kinetic parameters
Steady-state kinetic parameters (K m and V max ) were determined by measuring substrate hydrolysis under initial rate conditions and using the Hanes-Wolf linearization from the Michaelis-Menten equation. 25 The reactions for kinetic measurements were performed at 258C in HB buffer. Cells with path lengths of 0.2-1 cm were used, depending on the substrate concentration. The interaction with the following chelating agents [EDTA, 1,10-o-phenantroline and pyridine-2,6-dicarboxylic (dipicolinic) acid] was determined by incubating 0.1 mM enzyme at 258C for 15 min with increasing inhibitor concentration. The rate of hydrolysis at a steady state was measured by using 100 mM nitrocefin as the reporter substrate. In order to determine the dependence of zinc content on IMP-22 activity, the hydrolysis rate of 100 mM imipenem was measured using a concentration of ZnCl 2 from 10 to 200 mM. The hydrolysis of ZnCl 2 alone at the same concentrations was also measured as a control.
Computer sequence analysis
The establishing of nucleotide sequences and their deduced protein products and a comparison of sequences were carried out using the Vector NTI 9 software package (Invitrogen, InforMax, Inc.).
Nucleotide sequence accession number
The nucleotide sequence of the bla IMP-22 -orfXX-containing gene cassettes described in this paper was submitted to the IMP-22, a new zinc enzyme in Pseudomonas spp.
EMBL/GenBank/DDBJ sequence databases and was assigned the following accession number: DQ361087.
Results and discussion
Sequence analysis of the IMP-22 enzyme P. fluorescens, strains AQ/05 and AQ/06, and P. aeruginosa AQ/07 encoded a new metallo-b-lactamase belonging to the IMP family, IMP-22. The bla IMP-22 gene was 741 bp long and encodes a pre-protein of 246 amino acids. The N-terminus sequence, determined on purified enzyme obtained from an E. coli recombinant strain with the help of a gas-phase sequencer, showed the following sequence: NH 2 -PDLK. The signal peptide sequence consisted of 22 amino acid residues. Our multiple sequence alignment analysis with other IMP variants suggested the closest similarity of IMP-22 enzyme with IMP-16 (94% amino acid identity). With respect to IMP-1 (accession number S71932), this was shown to share only 85% identity. Moreover, IMP-22 was found to carry three unique amino acid substitutions never described in the other IMP variants. The amino acid substitutions are the following: E104D, K108Q and E174V (standard numbering by Galleni et al. 26 ).
MIC experiments
In order to determine the functionality of bla IMP-22 , the gene was amplified by PCR and ligated into a pBC-SK vector and the recombinant strain (E. coli DH5a/pBC-SK/bla IMP-22 ) was tested for in vitro susceptibility against several b-lactam molecules (Table 2) . MIC values were also evaluated for P. fluorescens AQ/05, P. fluorescens AQ/06 and P. aeruginosa AQ/07 in comparison with E. coli DH5a recipient cells. Results of these experiments showed that P. fluorescens AQ/05 and AQ/06 were resistant to cephalosporins (cefazolin, cefotaxime, ceftazidime and cefepime) but susceptible to penicillins (amoxicillin and piperacillin), amikacin and aztreonam. P. fluorescens AQ/06 also exhibited a resistance profile against fluoroquinolones (an MIC value of 8 mg/L for levofloxacin). P. aeruginosa AQ/07 was found to be resistant to all the b-lactams tested. IMP-22 b-lactamase seems to confer resistance to cefazolin, cefotaxime and ceftazidime. The recombinant strain E. coli DH5a/pBC-SK/bla showed the MIC values of imipenem and meropenem to be less than that observed for P. fluorescens AQ/5 and AQ/6.
Molecular analysis
Despite several attempts the presence of plasmidic DNA was not observed in P. fluorescens strains AQ/05 and AQ/06, and conjugation experiments using P. aeruginosa PAO1 of putative plasmid DNA failed, suggesting a chromosomal location of the bla IMP-22 gene. RAPD analysis performed on P. fluorescens AQ/05 and P. fluorescens AQ/06 showed a different profile for the two strains (data not shown). Southern blot analysis showed the presence of bla IMP-22 gene in a large plasmid extracted from P. aeruginosa AQ/07 and in chromosomal DNA of P. fluorescens strains.
Structure of integrons P. fluorescens AQ/05 and AQ/06 and P. aeruginosa AQ/07 isolates were also analysed by PCR for the presence of integrons, using the primers listed in Table 1 . All organisms showed a class 1 integron with the same 5 0 CS and 3 0 CS regions and different gene cassettes (Figure 1 ). The 5 0 CS of the three integrons carried the integrase gene IntI1 of 1014 bp, the promoter region and the attI1 site. The 3 0 CS end included qacED1 and sul1 genes, conferring resistance to quaternary ammonium compounds and sulphonamides, respectively.
As shown in Figure 1 (a) and in more detail in Figure 2 , the integron isolated from P. fluorescens AQ/05 possesses a variable region of 1281 bp characterized by the bla IMP-22 gene, immediately downstream of 5 0 CS: this gene was preceded by typical features of an attI site with a putative core site (GTTAGAA) and inverse core site (CCCTAAA). The P1 promoter had features of an intermediate strong promoter; its regions 235 (TGGACA) and 210 (TAAACT) were spaced by 17 bp. The P2 promoter [235 (TTGTTA) and 210 (TACAGT)], 80 bp downstream of P1, was in the inactive form, which indicates that only the P1 promoter drives the expression of the gene cassettes inserted into the integron. bla IMP-22 is followed by a 59be region, 133 bp long and is very similar to 59be sequence of bla IMP-16 (85.2% identity); 27 1L, 2L, 1R and 2R regions were also found in the 59be core site.
The second gene cassette is 511 bp long and contains an open reading frame (ORF) of 327 bp (designed as orfXX), potentially encoding a protein of 108 residues of unknown function. No significant similarities were observed between this hypothetical protein and any other known sequenced protein in BLAST database.
The integron isolated from P. fluorescens AQ/06 (Figure 1b ) presents a variable region of 1910 bp with three gene cassettes: bla IMP-22 and orfXX and the aacA4 gene cassette of 629 bp. bla IMP-22 and orfXX gene cassettes share 100% identity with those isolated from P. fluorescens AQ/05. The nosocomial strain P. aeruginosa AQ/07 harbours an integron ( Figure 1c ) with a variable region of 1188 bp that contains an aacA4 (555 bp) and catB10 (633 bp), which encode a chloramphenicol acetyltransferase described previously (accession number AJ878850). The bla IMP-22 gene was not located in this integron.
Characterization of IMP-22, a new metalloenzyme
In order to overproduce IMP-22, the bla IMP-22 gene was ligated into the pET-26b(þ) vector and the recombinant plasmid was inserted into E. coli BL21(DE3), E. coli BL21(DE3)pLys and E. coli BL21(DE3)Rosetta. b-Lactamase production was monitored by measuring specific activity against imipenem in periplasmic extract (data not shown). The best results in terms of production were obtained after the addition of 0.4 mM IPTG, after 2 h of growth of E. coli BL21(DE3)Rosetta. Therefore, IMP-22 was extracted from the periplasmic space and purified by three chromatographic steps (Sepharose Q, Superdex 75 and Superose 12), which yielded the enzyme as 80% pure, as evaluated by SDS-PAGE analysis. Further attempts to obtain a higher degree of purity in the enzyme failed. The molecular mass and pI calculated for IMP-22 were 24930 Da and 6.2, respectively. The molecular mass determined on the basis of the N-terminal sequence was in good agreement with that determined by SDS-PAGE (25 kDa) .
For all the substrates tested, the authors calculated the V max values because the enzyme was estimated to be pure at 80%. As shown in Table 3 , IMP-22 was able to hydrolyse all b-lactams used except aztreonam. Higher values of K m for penicillins (i.e. K m . 1500 mM for piperacillin) but lower values for cefazolin and meropenem (K m ¼ 2 mM for both) were observed. With regard to relative V max , imipenem acted as a good substrate with V max values of 2-, 10-and 270-fold higher than ampicillin, benzylpenicillin and piperacillin, respectively. V max values ranged from 29-to 75-fold higher than cephalosporins and were also 52-fold higher than meropenem.
The activity of IMP-22 was found to be inhibited by chelating agents such as EDTA, 1-10-o-phenanthroline and dipicolinic acid. The IC 50 s of EDTA, 1-10-o-phenanthroline and dipicolinic acid were 800, 750 and 300 mM, respectively.
At pH 7.5, when increasing Zn 2þ ion concentrations were added to the enzyme, the activity of imipenem hydrolysis was not affected. The influence of ZnCl 2 concentration (10-200 mM) on the hydrolysis of imipenem in this range was negligible.
IMP-22 metallo-b-lactamase was shown to be phylogenetically related to IMP-16 (94% amino acid identity), while it was shown to be quite distant from IMP-1 (85% amino acid identity). A comparison with relative k cat of IMP-1 and IMP-16 7, 27 is shown in Table 3 . Although IMP-22 was found to be phylogenetically much more related to IMP-16, IMP-22 does not show any difference in the catalytic environment with respect to IMP-1. This observation could explain the K m values observed. In fact, K m values measured for IMP-22 were much more similar to IMP-1 than to IMP-16 (Table 3 ). In contrast with IMP-16, penicillins were found to be good substrates for IMP-22, while cephalosporins were poorly hydrolysed. If we compare the relative V max of IMP-22 with the relative k cat of IMP-16 and IMP-1 (see last column of Table 3 ), IMP-22 was shown to hydrolyse very efficiently all the drugs tested. In particular, IMP-22 hydrolysed imipenem and meropenem at the respective rates of 100 and 10 times higher than did IMP-16. IMP-22 presents three amino acid substitutions never found in other IMP enzymes (E104D, K108Q and E174V). It is likely that the three amino acid substitutions do not influence the catalytic aspect of the IMP-22 enzyme.
Mobilization of the bla IMP-22 gene
The bla IMP-22 gene was found in two non-related carbapenemresistant P. fluorescens collected from wastewater and in one carbapenem-resistant P. aeruginosa isolated from a L'Aquila teaching hospital, Italy. IMP-22, a new zinc enzyme in Pseudomonas spp.
environmental strains also suggests the ongoing spread of bla MBL in several bacterial species and in different environments. 7, 13 Although the location of bla IMP in integron-borne cassettes has been reported previously, 28 the combination of bla IMP-22 and orfXX cassettes in the class 1 integron was described for the first time in this study.
Generally, environmental strains mainly lack the sul1 gene, 12 which is usual for integrons found in clinical isolates, with rare exceptions. 12 The difference in the basic structure of the integrons found in clinical and environmental strains probably reflects the different selective pressure to which the bacteria are exposed. The sul1 genetic determinants for sulphonamide resistance are still very common in the genetic elements of Gram-negative bacteria and this could be explained by the fact that they are integrated very efficiently into genetic elements such as integrons. 12 Figure 2. DNA and amino acid sequences of the bla IMP-22 -carrying integron and its gene. The start and stop codons of the ORFs are indicated by horizontal arrows and asterisks, respectively. The corresponding predicted protein translation is reported below the DNA sequence. The slashes represent the cleavage site of the signal sequence of IMP-22. The conserved 7 bp core sites located at the cassette boundaries and the 7 bp inverse core sites located at the left end of each 59be are boxed. The recombination crossover sites are indicated by vertical arrows. The 59be conserved sequences are highlighted in bold and are labelled 1L, 2L, 2R and 1R. The putative ribosome-binding sites are highlighted in bold, are underlined and are labelled RBS. The entire sequence has been assigned EMBL/GenBank accession number DQ361087.
Although it is commonly accepted that antibiotic resistance has evolved in the natural environment, the extensive use of those molecules in human and veterinary medicine represents the driving force leading to the evolution and maintenance of resistance genes. 18 Those determinants are subsequently transferred to the natural environment that becomes the reservoir of those resistance genes. 18 Therefore, it is important to be able to develop rapid diagnostic methods in order to trace and rapidly localize the spread of resistance genes, not only in a confined clinical setting but also in the open environment.
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